These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3353781)

  • 1. [Dosage of tricyclic antidepressive agents. Monitoring and guide to therapy].
    Vandel S
    Soins Psychiatr; 1988 Feb; (88):27-34. PubMed ID: 3353781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of the therapy of depression with tricyclic antidepressive agents].
    Gram LF; Kragh-Sørensen P; Nagy A; Dencker SJ; Lunde PK
    Ugeskr Laeger; 1981 Jan; 143(5):252-7. PubMed ID: 7210226
    [No Abstract]   [Full Text] [Related]  

  • 3. On the role of plasma level monitoring of tricyclic antidepressants in clinical practice.
    Asberg M; Sjöqvist F
    Commun Psychopharmacol; 1978; 2(5):381-91. PubMed ID: 738018
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial severity and diagnosis influence the relationship of tricyclic plasma levels to response: a statistical review.
    Boyer WF; Lake CR
    J Clin Psychopharmacol; 1987 Apr; 7(2):67-71. PubMed ID: 3584523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children.
    Preskorn SH; Weller E; Hughes C; Weller R
    Clin Neuropharmacol; 1986; 9 Suppl 4():265-7. PubMed ID: 3552217
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal dosage of tricyclic antidepressants.
    Kripke C
    Am Fam Physician; 2004 Oct; 70(7):1270. PubMed ID: 15508537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1993; 27(6):683-91. PubMed ID: 8134502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of depression: benefits and limits of blood levels of tricyclic antidepressants].
    Baumann P
    Schweiz Med Wochenschr; 1981 Feb; 111(7):228-39. PubMed ID: 7013064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tricyclic antidepressant concentrations to determine individual response.
    Morin A; Stoukides CA
    Ann Pharmacother; 1993; 27(7-8):896-7. PubMed ID: 8364275
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine-tricyclic combinations.
    Zelwer A
    Aust N Z J Psychiatry; 1993 Jun; 27(2):350, 352. PubMed ID: 8363551
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants.
    Gram LF; Pedersen OL; Kristensen CB; Bjerre M; Kragh-Sørensen P
    Ther Drug Monit; 1982; 4(1):17-25. PubMed ID: 7041335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reassessment of tricyclics and E.C.T. in depression.
    Kramer H; Spring G
    Dis Nerv Syst; 1977 Aug; 38(8):641-3. PubMed ID: 885040
    [No Abstract]   [Full Text] [Related]  

  • 17. Once-a-day dosage tricyclic antidepressant drug therapy: a survey.
    Ayd FJ
    Dis Nerv Syst; 1974 Oct; 35(10):475-80. PubMed ID: 17894062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine].
    Jarema M
    Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical evaluation of the value and limitations of plasma assays of imipramine derivatives for therapeutic monitoring].
    Bonin B; Vandel B; Vandel S; Volmat R
    Therapie; 1986; 41(2):115-8. PubMed ID: 3726782
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring tricyclic antidepressant plasma levels.
    Sato TL; Madakasira S
    Am Fam Physician; 1984 May; 29(5):199-202. PubMed ID: 6731239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.